[Treatment of parkinsonism with L-Dopa associated with decarboxylase inhibitors. II].
D000328:Adult; D000368:Aged; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage* / Q000009:adverse effects; D004296:Dopa Decarboxylase / Q000009:adverse effects; D004357:Drug Synergism; D006801:Humans; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D013997:Time Factors
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004295:Dihydroxyphenylalanine; D004296:Dopa Decarboxylase
Thérapeutique du syndrome parkinsonien par la L-Dopa associée à des inhibiteurs de la décarboxylase. I.